BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20443814)

  • 1. Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis.
    Boucher M; Pesant S; Lei YH; Nanton N; Most P; Eckhart AD; Koch WJ; Gao E
    Clin Transl Sci; 2008 May; 1(1):13-20. PubMed ID: 20443814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart.
    Gao E; Boucher M; Chuprun JK; Zhou RH; Eckhart AD; Koch WJ
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H60-8. PubMed ID: 17384131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
    Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress.
    Ji L; Fu F; Zhang L; Liu W; Cai X; Zhang L; Zheng Q; Zhang H; Gao F
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E871-80. PubMed ID: 20124508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term cardioprotective effect of darbepoetin-alpha: role of Bcl-2 family proteins.
    Schlecht-Bauer D; Antier D; Machet MC; Hyvelin JM
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):223-31. PubMed ID: 19597369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1.
    Song CL; Liu B; Diao HY; Shi YF; Zhang JC; Li YX; Liu N; Yu YP; Wang G; Wang JP; Li Q
    Oncotarget; 2016 Jun; 7(26):39740-39757. PubMed ID: 27175593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
    Kiss K; Csonka C; Pálóczi J; Pipis J; Görbe A; Kocsis GF; Murlasits Z; Sárközy M; Szűcs G; Holmes CP; Pan Y; Bhandari A; Csont T; Shamloo M; Woodburn KW; Ferdinandy P; Bencsik P
    Pharmacol Res; 2016 Nov; 113(Pt A):62-70. PubMed ID: 27521836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
    Baker JE; Kozik D; Hsu AK; Fu X; Tweddell JS; Gross GJ
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):337-45. PubMed ID: 17577097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
    Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
    J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
    Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shengmai injection reduces apoptosis and enhances angiogenesis after myocardial ischaemia and reperfusion injury in rats.
    Liu X; Tan W; Yang F; Wang Y; Yue S; Wang T; Wang X
    Biomed Pharmacother; 2018 Aug; 104():629-636. PubMed ID: 29803176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion.
    Buerke M; Murohara T; Skurk C; Nuss C; Tomaselli K; Lefer AM
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8031-5. PubMed ID: 7644533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
    Lipsic E; van der Meer P; Voors AA; Westenbrink BD; van den Heuvel AF; de Boer HC; van Zonneveld AJ; Schoemaker RG; van Gilst WH; Zijlstra F; van Veldhuisen DJ
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):135-41. PubMed ID: 16761193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells.
    Fishbane S; Ragolia L; Palaia T; Johnson B; Elzein H; Maesaka JK
    Kidney Int; 2004 Feb; 65(2):452-8. PubMed ID: 14717915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 enhances the efficacy of myoblast transplantation with its multiple functions in the chronic myocardial infarction rat model.
    Kanemitsu N; Tambara K; Premaratne GU; Kimura Y; Tomita S; Kawamura T; Hasegawa K; Tabata Y; Komeda M
    J Heart Lung Transplant; 2006 Oct; 25(10):1253-62. PubMed ID: 17045939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor.
    Kanellakis P; Pomilio G; Agrotis A; Gao X; Du XJ; Curtis D; Bobik A
    Br J Pharmacol; 2010 Aug; 160(8):2085-96. PubMed ID: 20649603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
    Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
    J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
    van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.